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When less-virulent becomes virulent!! An atypical presentation of
Streptococcus Viridians.
Samreen Khan MD, MPH. Stavan Patel MS, MD. Mary Anne Nidiry MD.

Introduction

Peripheral signs of IE

Discussion
• S.viridans is part of the normal flora of the

• Infective endocarditis (IE) is a life-threatening
disease, and its timely diagnosis, antibiotic treatment,
and management of complications is critical to
optimal outcomes.

mouth which can cause dental caries,
pericoronitis and subacute IE.
• Infections with Viridians Streptococcal is not

uncommon but are routinely seen in those with
underlying heart disease and dental
manipulation.

• We present a case of a 45-year-old man with noknown risk factors who presented in respiratory
distress and was found to have viridians
streptococcal aortic valve endocarditis.

Case Presentation

• S.Viridians is responsible for up-to 40-60% of IE

Modified Duke Criteria for Diagnosis of IE

• 45 y/o male with no significant PMH

presented with worsening dyspnea, fevers
and chills.
Upon Arrival
• Temp 101.3, BP 125/67, P 122, RR 26
• In respiratory distress, had b/l rales, no
murmurs, no raised JVD, no peripheral
edema
• CXR showed mild cardiomegaly with
pulmonary vascular congestion.

•
•
•

•
•

•

•
•

•

Clinical Course
Reported new onset of chest heaviness and
cough while in ED.
Rapid deterioration in respiratory status
which required urgent intubation.
Urgent bronchoscopy done in setting of
acute hypoxic respiratory failure with
concerns for multi-focal pneumonia,
revealing diffuse alveolar hemorrhage.
Started on broad spectrum treatment for
both bacterial and viral causes of ARDS.
ECHO showed severe aortic insufficiency
related to suspected large vegetation with
leaflet disruption.
Intraoperative finding of aortic intraannular abcess requiring emergent
aortic valve replacement.
Blood cultures grew streptococcus
viridians.
Though clinical course was complicated by
cardiogenic shock and multi-organ failure,
he fortunately made full recovery.
Completed a six weeks course of
antibiotics.

in normal valves and in patients (young males
and over 45 years of age) usually with mitral
valves.
• With S. viridians endocarditis, it is commonly

associated with heart failure and lesion such as
peri-annular abscesses, fistulas, or pseudoaneurysms with risk of mortality at 15%
• Our report discusses a rather unusual

presentation of a patient who is
immunocompetent with no risk factors
developing Viridians Streptococcal bacteremia
with infective endocarditis of the aortic valve
with inter-operative findings of aortic intraannular abscess.

TTE showing Aortic Insufficiency and
questionable vegetation and leaflet disruption
A

Take Home Messages
•

Despite advances in medical, surgical and critical
care interventions, IE remains a life-threatening
illness.

•

Though subacute IE is commonly associated with S.
viridans its presentation can be atypical. In
addition patient had no known risk factors which
would contribute to the development of IE.

•

Risk factors for IE
• Cardiac factors (history of
prior IE or pre-existing
valvular or congenital heart
disease),
• Underlying conditions (such
as intravenous drug use, an
indwelling intravenous
catheter, or
immunosuppression),
• Recent dental or surgical
procedure.

•

The rate at which S. viridans IE occurs in those
without any dental manipulation, as of this case
report, is unclear.

•

On initial presentation IE was not excepted and
patient was placed on broad coverage antibiotics
for both viral and bacterial causes of ARDS.

•

Early ECHO can be instrumental in early diagnosis
of IE.

•

The lack of supporting data in history and minimal
findings on histopathology does not always exclude
this pathogen as a cause.

Treatment
Treatment regimens for native
valve endocarditis due to penicillinsusceptible viridans streptococci
• Aqueous penicillin or Ampicillin
or Ceftriaxone for 4 weeks
• Beta-lactam-intolerant patients:
Vancomycin
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